Literature DB >> 30449522

The Treatment of Laryngeal Cancer.

Randa Obid1, Magi Redlich2, Chafeek Tomeh3.   

Abstract

Successful management of laryngeal cancer depends on careful pretreatment evaluation of patient and disease factors to arrive at accurate staging, leading to appropriate treatment selection for patients with this highly impacting disease. Surgical modalities, including transoral laser microsurgery, open partial laryngectomy, and total laryngectomy, offer options, alone or in combination with radiation and chemotherapy. Treatment strategy for laryngeal cancer should strive for cure while maintaining the best quality of life possible for the patient. Achieving the goals of initial and salvage treatment for laryngeal cancer depends on executing a plan of care determined by the expertise of the multidisciplinary team.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AJCC staging; Laryngeal cancer; Laryngectomy; Neck dissection; Open partial laryngectomy; Organ preservation; Squamous cell carcinoma; Transoral laser microsurgery

Mesh:

Year:  2019        PMID: 30449522     DOI: 10.1016/j.coms.2018.09.001

Source DB:  PubMed          Journal:  Oral Maxillofac Surg Clin North Am        ISSN: 1042-3699            Impact factor:   2.802


  23 in total

1.  Identification of MSC-AS1, a novel lncRNA for the diagnosis of laryngeal cancer.

Authors:  Yudong Liu; Wenxia Meng; Huan Cao; Baoshan Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-10-20       Impact factor: 2.503

2.  LncRNA MALAT1 inhibits the proliferation and invasiveness of laryngeal squamous cell carcinoma Hep-2 cells by modulating miR-362-3p.

Authors:  Baotong Xie; Zhaohua Wang; Tao Li; Junfang Xue; Chunming Zhang
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

3.  Hsa_circ_0006232 promotes laryngeal squamous cell cancer progression through FUS-mediated EZH2 stabilization.

Authors:  Tianyi Wu; Guangke Wang; Xianting Zeng; Zhanwei Sun; Shichao Li; Weiwei Wang; Boyu Yu
Journal:  Cell Cycle       Date:  2021-08-26       Impact factor: 5.173

4.  NLR, PLR, LMR and MWR as diagnostic and prognostic markers for laryngeal carcinoma.

Authors:  Pingdong Li; Haiyang Li; Shuo Ding; Jing Zhou
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

5.  Tumor-derived exosomal microRNA-15b-5p augments laryngeal cancer by targeting TXNIP.

Authors:  Feng Yu; Ying Lin; Guojie Tan; Maomao Ai; Huicheng Gong; Wei Liu; Jiali Huang; Zirou Zou
Journal:  Cell Cycle       Date:  2022-02-13       Impact factor: 5.173

6.  Prognostic value of a microRNA-pair signature in laryngeal squamous cell carcinoma patients.

Authors:  Shu Zhou; Qingchun Meng; Zexuan Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-04-27       Impact factor: 3.236

7.  Effect of a refined nursing model based on nursing quality feedback on the postoperative mental state of patients with laryngeal cancer.

Authors:  Kailian He; Quanqing Li; Yuqing Hou; Yulin He; Xiaozhen Yue
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

8.  Anti-CD47 antibody synergizes with cisplatin against laryngeal cancer by enhancing phagocytic ability of macrophages.

Authors:  Jingmiao Wang; Haizhong Zhang; Xiaoyan Yin; Yanrui Bian
Journal:  Clin Exp Immunol       Date:  2021-06-08       Impact factor: 5.732

9.  Long intergenic non-protein coding RNA 847 promotes laryngeal squamous cell carcinoma progression through the microRNA-181a-5p/zinc finger E-box binding homeobox 2 axis.

Authors:  Wei Li; Xionghui Hu; Xiaolin Huang
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

10.  Hsa_circ_0042823 accelerates cancer progression via miR-877-5p/FOXM1 axis in laryngeal squamous cell carcinoma.

Authors:  Tianyi Wu; Yanan Sun; Zhanwei Sun; Shichao Li; Weiwei Wang; Boyu Yu; Guangke Wang
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.